7Baggers

HCA Healthcare, Inc
(NYSE:HCA) 

HCA stock logo

HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; an...

Founded: 1968
Full Time Employees: 210,000
Sector: Healthcare
Industry: Medical Care Facilities
Healthcare
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-05-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 
                                                                         
      revenues
    		19,109,000,000 19,513,000,000 19,161,000,000 18,605,000,000 18,321,000,000 18,285,000,000 17,487,000,000 17,492,000,000 17,339,000,000 17,303,000,000 16,213,000,000 15,861,000,000 15,591,000,000 15,497,000,000 14,971,000,000 14,820,000,000 14,945,000,000 15,064,000,000 15,276,000,000 14,435,000,000 13,977,000,000 14,293,000,000 13,311,000,000 11,068,000,000 12,861,000,000 13,523,000,000 12,694,000,000 12,602,000,000 12,517,000,000 12,274,000,000 11,451,000,000 11,529,000,000 11,423,000,000 11,562,000,000 10,696,000,000 10,733,000,000 10,623,000,000 10,641,000,000 10,270,000,000 10,319,000,000 10,260,000,000 10,249,000,000 9,856,000,000 9,897,000,000 9,676,000,000 9,636,000,000 9,220,000,000 9,230,000,000 8,832,000,000 8,836,000,000 8,456,000,000 8,450,000,000 8,440,000,000 8,434,000,000 8,062,000,000 8,112,000,000 8,405,000,000 7,678,000,000 7,310,000,000 8,063,000,000 8,055,000,000 7,736,000,000 7,647,000,000 7,756,000,000      
      salaries and benefits
    		8,283,000,000 8,360,000,000 8,364,000,000 8,138,000,000 7,997,000,000 7,917,000,000 7,861,000,000 7,685,000,000 7,707,000,000 7,570,000,000 7,556,000,000 7,277,000,000 7,084,000,000 7,055,000,000 6,899,000,000 6,792,000,000 6,939,000,000 6,999,000,000 7,094,000,000 6,385,000,000 6,301,000,000 6,329,000,000 6,097,000,000 5,330,000,000 6,118,000,000 6,105,000,000 5,971,000,000 5,837,000,000 5,647,000,000 5,485,000,000 5,377,000,000 5,274,000,000 5,289,000,000 5,181,000,000 5,081,000,000 4,896,000,000 4,901,000,000 4,764,000,000 4,740,000,000 4,691,000,000 4,702,000,000 4,606,000,000 4,619,000,000 4,492,000,000 4,398,000,000 4,282,000,000 4,211,000,000 4,098,000,000 4,050,000,000 3,965,000,000 3,916,000,000 3,848,000,000 3,917,000,000 3,865,000,000 3,781,000,000 3,707,000,000 3,736,000,000 3,492,000,000 3,333,000,000 3,320,000,000 3,295,000,000 3,202,000,000 3,134,000,000 3,076,000,000      
      supplies
    		2,853,000,000 2,977,000,000 2,782,000,000 2,844,000,000 2,764,000,000 2,793,000,000 2,657,000,000 2,634,000,000 2,671,000,000 2,584,000,000 2,417,000,000 2,478,000,000 2,423,000,000 2,429,000,000 2,320,000,000 2,301,000,000 2,321,000,000 2,414,000,000 2,463,000,000 2,380,000,000 2,224,000,000 2,370,000,000 2,128,000,000 1,748,000,000 2,123,000,000 2,232,000,000 2,090,000,000 2,118,000,000 2,041,000,000 2,002,000,000 1,890,000,000 1,917,000,000 1,915,000,000 1,947,000,000 1,777,000,000 1,795,000,000 1,797,000,000 1,802,000,000 1,699,000,000 1,718,000,000 1,714,000,000 1,686,000,000 1,644,000,000 1,670,000,000 1,638,000,000 1,659,000,000 1,539,000,000 1,532,000,000 1,532,000,000 1,564,000,000 1,457,000,000 1,470,000,000 1,479,000,000 1,501,000,000 1,375,000,000 1,422,000,000 1,419,000,000 1,346,000,000 1,263,000,000 1,295,000,000 1,275,000,000 1,276,000,000 1,234,000,000 1,251,000,000      
      other operating expenses
    		4,180,000,000 4,087,000,000 4,161,000,000 3,793,000,000 3,845,000,000 3,873,000,000 3,717,000,000 3,623,000,000 3,606,000,000 3,559,000,000 3,379,000,000 3,043,000,000 2,894,000,000 2,850,000,000 2,860,000,000 2,693,000,000 2,752,000,000 2,537,000,000 2,530,000,000 2,473,000,000 2,421,000,000 2,482,000,000 2,251,000,000 2,147,000,000 2,427,000,000 2,468,000,000 2,352,000,000 2,362,000,000 2,299,000,000 2,283,000,000 2,097,000,000 2,118,000,000 2,110,000,000 2,081,000,000 2,075,000,000 1,965,000,000 1,930,000,000 1,881,000,000 1,897,000,000 1,873,000,000 1,857,000,000 1,835,000,000 1,796,000,000 1,755,000,000 1,717,000,000 1,778,000,000 1,688,000,000 1,644,000,000 1,645,000,000 1,643,000,000 1,564,000,000 1,507,000,000 1,523,000,000 1,552,000,000 1,510,000,000 1,493,000,000 1,493,000,000 1,452,000,000 1,370,000,000 1,326,000,000 1,322,000,000 1,308,000,000 1,268,000,000 1,226,000,000      
      equity in earnings of affiliates
    		-9,000,000 -25,000,000 -16,000,000           -16,000,000 -10,000,000 -8,000,000 -11,000,000 -35,000,000 -35,000,000 -22,000,000 -21,000,000 -6,000,000 -40,000,000 -1,000,000 -7,000,000 -20,000,000 -4,000,000 -8,000,000 -11,000,000 -4,000,000 -9,000,000 -7,000,000 -9,000,000 -9,000,000 -13,000,000 -13,000,000 -10,000,000 -10,000,000 -22,000,000 -10,000,000 -12,000,000 -8,000,000 -9,000,000 -10,000,000 -19,000,000 -11,000,000 -14,000,000 -9,000,000 -9,000,000  -9,000,000 -12,000,000 -8,000,000 -10,000,000 -6,000,000 -9,000,000 -11,000,000 -41,000,000 -68,000,000 -73,000,000 -76,000,000 -72,000,000 -67,000,000 -75,000,000      
      depreciation and amortization
    		930,000,000 911,000,000 889,000,000 863,000,000 860,000,000 856,000,000 842,000,000 819,000,000 795,000,000 789,000,000 769,000,000 763,000,000 756,000,000 750,000,000 749,000,000 738,000,000 732,000,000 728,000,000 716,000,000 712,000,000 697,000,000 662,000,000 694,000,000 691,000,000 674,000,000 694,000,000 647,000,000 636,000,000 619,000,000 581,000,000 582,000,000 562,000,000 553,000,000 550,000,000 539,000,000 521,000,000 521,000,000 503,000,000 495,000,000 489,000,000 479,000,000 480,000,000 482,000,000 469,000,000 473,000,000 459,000,000 460,000,000 454,000,000 447,000,000 461,000,000 443,000,000 425,000,000 424,000,000 425,000,000 417,000,000 420,000,000 417,000,000 387,000,000 362,000,000 358,000,000 358,000,000 359,000,000 352,000,000 355,000,000      
      interest expense
    		584,000,000 572,000,000 561,000,000 568,000,000 547,000,000 528,000,000 515,000,000 506,000,000 512,000,000 491,000,000 483,000,000 485,000,000 479,000,000 453,000,000 446,000,000 434,000,000 408,000,000 398,000,000 398,000,000 386,000,000 384,000,000 383,000,000 385,000,000 388,000,000 428,000,000 438,000,000 448,000,000 477,000,000 461,000,000 446,000,000 442,000,000 436,000,000 431,000,000 433,000,000 427,000,000 411,000,000 419,000,000 432,000,000 432,000,000 427,000,000 416,000,000 410,000,000 411,000,000 425,000,000 419,000,000 429,000,000 427,000,000 427,000,000 460,000,000 456,000,000 458,000,000 462,000,000 472,000,000 462,000,000 446,000,000 448,000,000 442,000,000 465,000,000 519,000,000 520,000,000 533,000,000 526,000,000 525,000,000 530,000,000      
      losses on sales of facilities
    		1,000,000 -41,000,000 2,000,000 3,000,000  195,000,000 4,000,000 -12,000,000 -201,000,000 -7,000,000 -2,000,000 -1,000,000 15,000,000 -1,326,000,000 3,000,000 32,000,000                                     16,000,000   2,000,000 1,000,000 750,000 2,000,000  1,000,000 -6,000,000 2,000,000       
      income before income taxes
    		2,287,000,000 2,672,000,000 2,418,000,000 2,415,000,000 2,327,000,000 2,133,000,000 1,906,000,000 2,237,000,000 2,247,000,000 2,345,000,000 1,630,000,000 1,809,000,000 1,922,000,000 3,302,000,000 1,704,000,000 1,760,000,000 1,814,000,000 2,586,000,000 3,157,000,000 2,117,000,000 1,973,000,000 2,072,000,000 988,000,000 1,560,000,000 810,000,000 1,607,000,000 979,000,000 1,198,000,000 1,460,000,000 1,489,000,000 1,069,000,000 1,238,000,000 1,539,000,000 1,377,000,000 778,000,000 1,160,000,000 1,066,000,000 1,565,000,000 1,018,000,000 1,132,000,000 1,095,000,000 1,052,000,000 843,000,000 984,000,000 1,078,000,000 968,000,000 929,000,000 904,000,000 680,000,000 800,000,000 701,000,000 806,000,000 639,000,000 555,000,000 677,000,000 699,000,000 963,000,000 2,454,000,000 123,000,000 467,000,000 517,000,000 564,000,000 468,000,000 514,000,000      
      provision for income taxes
    		430,000,000 509,000,000 515,000,000 524,000,000 502,000,000 447,000,000 424,000,000 550,000,000 445,000,000 484,000,000 355,000,000 397,000,000 379,000,000 656,000,000 360,000,000 381,000,000 349,000,000                                             170,000,000 143,000,000       
      net income
    		1,857,000,000 2,163,000,000 1,903,000,000 1,891,000,000 1,825,000,000 1,686,000,000 1,482,000,000 1,687,000,000 1,802,000,000 1,861,000,000 1,275,000,000 1,412,000,000 1,543,000,000 2,646,000,000 1,344,000,000 1,379,000,000 1,465,000,000 2,005,000,000 2,472,000,000 1,664,000,000 1,580,000,000 1,694,000,000 779,000,000 1,216,000,000 698,000,000 1,273,000,000 764,000,000 927,000,000 1,181,000,000 1,245,000,000 896,000,000 966,000,000 1,282,000,000 641,000,000 530,000,000 795,000,000 777,000,000 1,085,000,000 745,000,000 791,000,000 811,000,000 738,000,000 573,000,000 665,000,000 720,000,000 676,000,000 611,000,000 632,000,000 454,000,000 554,000,000 467,000,000 537,000,000 438,000,000 427,000,000 455,000,000 485,000,000 639,000,000 2,042,000,000 146,000,000 320,000,000 334,000,000 394,000,000 325,000,000 378,000,000      
      yoy
    		1.75% 28.29% 28.41% 12.09% 1.28% -9.40% 16.24% 19.48% 16.79% -29.67% -5.13% 2.39% 5.32% 31.97% -45.63% -17.13% -7.28% 18.36% 217.33% 36.84% 126.36% 33.07% 1.96% 31.18% -40.90% 2.25% -14.73% -4.04% -7.88% 94.23% 69.06% 21.51% 64.99% -40.92% -28.86% 0.51% -4.19% 47.02% 30.02% 18.95% 12.64% 9.17% -6.22% 5.22% 58.59% 22.02% 30.84% 17.69% 3.65% 29.74% 2.64% 10.72% -31.46% -79.09% 211.64% 51.56% 91.32% 418.27% -55.08% -15.34%          
      qoq
    		-14.15% 13.66% 0.63% 3.62% 8.24% 13.77% -12.15% -6.38% -3.17% 45.96% -9.70% -8.49% -41.69% 96.88% -2.54% -5.87% -26.93% -18.89% 48.56% 5.32% -6.73% 117.46% -35.94% 74.21% -45.17% 66.62% -17.58% -21.51% -5.14% 38.95% -7.25% -24.65% 100.00% 20.94% -33.33% 2.32% -28.39% 45.64% -5.82% -2.47% 9.89% 28.80% -13.83% -7.64% 6.51% 10.64% -3.32% 39.21% -18.05% 18.63% -13.04% 22.60% 2.58% -6.15% -6.19% -24.10% -68.71% 1298.63% -54.37% -4.19% -15.23% 21.23% -14.02%       
      net income attributable to noncontrolling interests
    		237,000,000 285,000,000 260,000,000 238,000,000 215,000,000 248,000,000 212,000,000 226,000,000 211,000,000 254,000,000 196,000,000 219,000,000 180,000,000 565,000,000 210,000,000 224,000,000 192,000,000 191,000,000 203,000,000 214,000,000 157,000,000 268,000,000 111,000,000 137,000,000 117,000,000 202,000,000 152,000,000 144,000,000 142,000,000 181,000,000 137,000,000 146,000,000 138,000,000 167,000,000 104,000,000 138,000,000 118,000,000 165,000,000 127,000,000 133,000,000 117,000,000 156,000,000 124,000,000 158,000,000 129,000,000 149,000,000 93,000,000 149,000,000 107,000,000 130,000,000 102,000,000 114,000,000 94,000,000 113,000,000 95,000,000 94,000,000 99,000,000 107,000,000 85,000,000 91,000,000 94,000,000 111,000,000 82,000,000 85,000,000      
      net income attributable to hca healthcare, inc.
    		1,620,000,000 1,878,000,000 1,643,000,000 1,653,000,000 1,610,000,000 1,438,000,000 1,270,000,000 1,461,000,000 1,591,000,000 1,607,000,000 1,079,000,000 1,193,000,000 1,363,000,000 2,081,000,000 1,134,000,000 1,155,000,000 1,273,000,000 1,814,000,000 2,269,000,000 1,450,000,000 1,423,000,000 1,426,000,000 668,000,000 1,079,000,000 581,000,000 1,071,000,000 612,000,000 783,000,000 1,039,000,000 1,064,000,000 759,000,000 820,000,000 1,144,000,000 474,000,000 426,000,000 657,000,000 659,000,000                                 
      per share data:
    		                                                                     
      basic earnings
    		7.25 5.118 7.05 6.91 6.52 4.143 4.94 5.6 6.01 3.315 3.98 4.35 4.92 3.033 3.97 3.95 4.21 3.918 7.13 4.42 4.21 1.723 1.97 3.2 1.72 1.78 1.8 2.29 3.03 1.955 2.2 2.35                                      
      diluted earnings
    		7.15 5.058 6.96 6.83 6.45 4.093 4.88 5.53 5.93 3.268 3.91 4.29 4.85 2.993 3.91 3.9 4.14 3.858 7 4.36 4.14 1.698 1.95 3.16 1.69 1.745 1.76 2.25 2.97 1.913 2.15 2.31                                      
      shares used in earnings per share calculations
    		                                                                     
      basic
    		223.588 -3.202 232.891 239.173 246.936 -2.167 256.763 261.156 264.435 -1.767 271.173 274.494 276.91 -3.235 285.958 292.527 302.446 -4.733 318.072 328.171 338.123 0.217 338.168 337.76 338.242 -0.722 340.789 342.17 342.876 -1.114 345.823 348.615 350.85 -3.093 360.17 365.847 370.289 -3.377 378.199 386.406 396.397 -2.953 414.939 416.407 420.148 -2,164 432,617 438,833 442,150 -1,059 447,329 446,612 444,401 737 440,899 439,473 437,936 -13,315 508,417 516,448 444,202 363 94,642 94,635      
      diluted
    		226.652 -2.964 236.181 241.911 249.44 -2.181 259.917 264.071 268.016 -1.761 275.424 278.198 280.961 -3.036 289.852 296.061 307.374 -4.496 324.029 332.613 343.321 0.591 343.346 341.599 344.096 -0.486 347.487 348.373 350.316 -0.821 353.639 355.039 359.749 -2.792 369.834 375.338 379.98 -3.726 389.592 398.659 410.575 -3.633 426.441 429.369 435.309 -2,186 447,260 453,009 457,449 -1,138 463,569 463,184 462,368 581 459,515 458,621 458,312 -13,640 527,515 538,557 461,969 362 97,454 97,026      
      equity in losses of affiliates
    		   -19,000,000 -18,000,000 -3,250,000 -15,000,000  2,000,000 1,500,000 -19,000,000 7,000,000 18,000,000                                                         
      gains on sales of facilities
    		    -1,000,000            -10,000,000    -2,000,000     -1,000,000  -18,000,000  -8,000,000 -6,000,000 -9,000,000 -405,000,000 -2,500,000 -7,000,000 -2,000,000         -9,000,000                         
      losses on retirement of debt
    		               78,000,000    12,000,000     295,000,000  211,000,000    9,000,000    39,000,000    4,000,000   10,000,000  125,000,000  109,000,000  226,000,000           406,000,000           
      government stimulus income reversal
    		                      822,000,000                                               
      losses (gains) on sales of facilities
    		                 -264,250,000 -1,047,000,000 -8,000,000  1,000,000 -14,000,000 27,000,000 -7,000,000    1,000,000        -1,000,000 -15,000,000 -3,000,000 -6,000,000 1,000,000 7,000,000 2,000,000 5,000,000  -9,000,000 12,000,000 -11,000,000 -21,000,000 -3,000,000 1,000,000 -4,000,000  -1,000,000 -7,000,000               
      benefit from income taxes
    		                 382,750,000 685,000,000 453,000,000 393,000,000 378,000,000 209,000,000 344,000,000 112,000,000 334,000,000 215,000,000 271,000,000 279,000,000 175,500,000 173,000,000 272,000,000 257,000,000 736,000,000 248,000,000 365,000,000 289,000,000 480,000,000 273,000,000 341,000,000 284,000,000 314,000,000 270,000,000 319,000,000 358,000,000 292,000,000 318,000,000 272,000,000 226,000,000 246,000,000 234,000,000 269,000,000 201,000,000   214,000,000 324,000,000   147,000,000 183,000,000   136,000,000      
      government stimulus income
    		                       -822,000,000                                              
      cash dividends declared
    		                               0.35                                      
      basic earnings per share
    		                                3.26 1.35 1.18 1.79 1.78 2.44 1.63 1.7 1.75 1.43 1.08 1.22 1.41 1.22 1.2 1.1 0.78 0.96 0.82 0.95 0.77 0.71 0.82 0.89 1.23 4.09 0.12 0.44 0.54 2.95 2.57 3.09      
      diluted earnings per share
    		                                3.18 1.31 1.15 1.75 1.74 2.37 1.59 1.65 1.69 1.39 1.05 1.18 1.36 1.18 1.16 1.07 0.76 0.93 0.79 0.91 0.74 0.68 0.78 0.85 1.18 3.93 0.11 0.43 0.52 2.88 2.49 3.01      
      cash dividends declared per share
    		                                0.35                     0.5   2             
      revenues before benefit from doubtful accounts
    		                                 12,497,000,000 11,967,000,000 11,806,000,000 11,383,000,000 8,310,250,000 11,110,000,000 11,081,000,000 11,050,000,000 8,067,000,000 11,014,000,000 10,932,000,000 10,322,000,000 7,404,750,000 9,978,000,000 9,958,000,000 9,683,000,000 7,019,500,000 9,411,000,000 9,473,000,000 9,194,000,000 6,811,250,000 8,893,000,000 9,153,000,000 9,199,000,000 6,042,000,000 8,050,000,000           
      benefit from doubtful accounts
    		                                 935,000,000 1,271,000,000 1,073,000,000 760,000,000 865,000,000 840,000,000 762,000,000 790,000,000 1,074,000,000 1,158,000,000 1,035,000,000 646,000,000 832,000,000 758,000,000 728,000,000 851,000,000 1,126,000,000 955,000,000 1,023,000,000 754,000,000 1,104,000,000 831,000,000 1,041,000,000 794,000,000 660,000,000 740,000,000 775,000,000 649,000,000   788,000,000      
      legal claim costs
    		                                     -279,000,000 11,000,000 10,000,000 12,000,000 172,000,000 77,000,000      78,000,000                     
      electronic health record incentive income
    		                                     -2,000,000 -1,000,000 -5,000,000 -4,000,000 -1,000,000 -9,000,000 -18,000,000 -19,000,000 -28,000,000 -32,000,000 -35,000,000 -30,000,000 -50,000,000 -75,000,000 -52,000,000 -39,000,000 -80,000,000 -131,000,000 -70,000,000 -55,000,000             
      net income attributable to hca holdings, inc.
    		                                     920,000,000 618,000,000 658,000,000 694,000,000 582,000,000 449,000,000 507,000,000 591,000,000 527,000,000 518,000,000 483,000,000 347,000,000 424,000,000 365,000,000 423,000,000 344,000,000 314,000,000 360,000,000 391,000,000 540,000,000 1,935,000,000 61,000,000 229,000,000 240,000,000         
      loss on retirement of debt
    		                                                 4,250,000   17,000,000       75,000,000          
      termination of management agreement
    		                                                            181,000,000         
      benefit for income taxes
    		                                                     190,000,000 222,000,000   76,750,000 -23,000,000           
      comprehensive income attributable to hca holdings, inc.
    		                                                     322.75 369 353 569             
      impairments of long-lived assets
    		                                                             4,000,000 10,000,000 91,000,000      
      provision for doubtful accounts
    		                                                             575,000,000 721,000,000       
      net income attributable to hca inc.
    		                                                             231,000,000 243,000,000 293,000,000      
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2026-03-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 
                                                                          
        assets
      		                                                                    
        current assets:
      		                                                                    
        cash and cash equivalents
      		940,000,000 997,000,000 939,000,000 1,060,000,000 1,933,000,000 2,888,000,000 831,000,000 1,284,000,000 935,000,000 891,000,000 862,000,000 842,000,000 908,000,000 999,000,000 858,000,000 2,371,000,000 1,451,000,000 1,027,000,000 1,120,000,000 1,030,000,000 1,793,000,000 6,588,000,000 4,638,000,000 731,000,000 621,000,000 559,000,000 2,430,000,000 531,000,000 502,000,000 578,000,000 868,000,000 1,086,000,000 732,000,000 718,000,000 705,000,000 753,000,000 646,000,000 677,000,000 691,000,000 852,000,000 741,000,000 588,000,000 673,000,000 586,000,000 566,000,000 515,000,000 658,000,000 850,000,000 414,000,000 484,000 462,000 594,000,000 705,000,000 472,000,000 518,000,000 471,000,000 373,000,000 359,000,000 539,000,000 553,000,000 411,000,000 377,000,000 350,000,000 388,000,000 312,000,000 443,000,000 450,000,000 356,000,000 
        accounts receivable
      		11,324,000,000 10,428,000,000 10,459,000,000 11,088,000,000 10,751,000,000 9,915,000,000 10,239,000,000 10,044,000,000 9,958,000,000 9,182,000,000 8,713,000,000 8,657,000,000 8,891,000,000 8,552,000,000 8,628,000,000 8,520,000,000 8,095,000,000 8,433,000,000 7,636,000,000 7,424,000,000 7,051,000,000 6,433,000,000 6,139,000,000 6,890,000,000 7,380,000,000 7,131,000,000 7,219,000,000 7,420,000,000 6,789,000,000 6,532,000,000 6,592,000,000 6,332,000,000   -1,752,000,000    -1,364,000,000   -2,976,000,000                           
        inventories
      		1,681,000,000 1,734,000,000 1,792,000,000 1,794,000,000 1,738,000,000 1,776,000,000 1,800,000,000 1,903,000,000 2,021,000,000 2,030,000,000 2,050,000,000 2,085,000,000 2,068,000,000 2,009,000,000 2,043,000,000 2,003,000,000 1,986,000,000 2,019,000,000 2,027,000,000 2,068,000,000 2,025,000,000 1,950,000,000 1,834,000,000 1,953,000,000 1,849,000,000 1,769,000,000 1,826,000,000 1,778,000,000 1,732,000,000 1,634,000,000 1,636,000,000 1,677,000,000 1,573,000,000 1,546,000,000 1,544,000,000 1,501,000,000 1,503,000,000 1,503,000,000 1,481,000,000 1,415,000,000 1,439,000,000 1,379,000,000 1,348,000,000 1,287,000,000 1,279,000,000 1,258,000,000 1,211,000,000 1,187,000,000 1,179,000,000 1,135,000 1,152,000 1,104,000,000 1,086,000,000 1,052,000,000 1,055,000,000 1,046,000,000 1,054,000,000 891,000,000 887,000,000 881,000,000 897,000,000 815,000,000 805,000,000 794,000,000 802,000,000 745,000,000 730,000,000 717,000,000 
        other
      		2,107,000,000 2,126,000,000 2,373,000,000 2,316,000,000 1,992,000,000 2,083,000,000 2,303,000,000 2,051,000,000 2,013,000,000 2,191,000,000 2,263,000,000 1,957,000,000 1,776,000,000 1,921,000,000 2,408,000,000 2,112,000,000 2,010,000,000 1,769,000,000 1,692,000,000 1,514,000,000 1,464,000,000 1,295,000,000 1,420,000,000 1,442,000,000 1,346,000,000 1,310,000,000 1,394,000,000 1,379,000,000 1,190,000,000 1,266,000,000 1,298,000,000 1,296,000,000 1,171,000,000 1,204,000,000 1,306,000,000 1,119,000,000 1,111,000,000 1,160,000,000 1,254,000,000 1,054,000,000 1,163,000,000 1,015,000,000 1,092,000,000 1,025,000,000 1,025,000,000 910,000,000 931,000,000 859,000,000 747,000,000 828,000 861,000 827,000,000 915,000,000 828,000,000 756,000,000 661,000,000 679,000,000 875,000,000 625,000,000 576,000,000 848,000,000 678,000,000 742,000,000 497,000,000 579,000,000 515,000,000 556,000,000 558,000,000 
        current assets: - sum
      		16,052,000,000     16,662,000,000 15,173,000,000  14,927,000,000 14,294,000,000 13,888,000,000  13,643,000,000 13,481,000,000 13,937,000,000 15,006,000,000 13,542,000,000                                            6,919,000,000 6,551,000,000   6,577,000,000 6,301,000,000  6,489,000,000 
        property and equipment, at cost
      		67,365,000,000 65,489,000,000 64,388,000,000 63,680,000,000  61,750,000,000 60,625,000,000 59,440,000,000  57,772,000,000 56,667,000,000 55,463,000,000  53,730,000,000 52,816,000,000 52,042,000,000  50,695,000,000 50,698,000,000 49,877,000,000  48,775,000,000 48,484,000,000 47,861,000,000  46,295,000,000 45,369,000,000 44,583,000,000  41,978,000,000 41,142,000,000 40,308,000,000  39,262,000,000 38,306,000,000 37,588,000,000  36,449,000,000 35,873,000,000 34,978,000,000  34,207,000,000 33,803,000,000 33,293,000,000  32,301,000,000 31,841,000,000 31,369,000,000  30,472,000 30,077,000 29,764,000,000  29,145,000,000 28,742,000,000 28,354,000,000  26,647,000,000 26,338,000,000 25,855,000,000  25,226,000,000 24,950,000,000 24,766,000,000  24,389,000,000 24,185,000,000 23,913,000,000 
        accumulated depreciation
      		-35,893,000,000 -34,921,000,000 -34,265,000,000 -33,942,000,000 -33,100,000,000 -32,703,000,000 -31,986,000,000 -31,344,000,000 -30,833,000,000 -30,655,000,000 -30,023,000,000 -29,410,000,000 -29,182,000,000 -28,752,000,000 -28,229,000,000 -27,814,000,000 -27,287,000,000 -27,148,000,000 -27,227,000,000 -26,689,000,000 -26,118,000,000 -25,834,000,000 -25,413,000,000 -24,876,000,000 -24,520,000,000 -24,293,000,000 -23,902,000,000 -23,455,000,000 -23,208,000,000 -22,937,000,000 -22,598,000,000 -22,184,000,000 -22,189,000,000 -21,933,000,000 -21,538,000,000 -21,126,000,000 -20,703,000,000 -20,574,000,000 -20,249,000,000 -19,921,000,000 -19,600,000,000 -19,503,000,000 -19,243,000,000 -18,901,000,000 -18,625,000,000 -18,423,000,000 -18,120,000,000 -17,757,000,000 -17,454,000,000 -17,150,000 -16,848,000 -16,620,000,000 -16,342,000,000 -16,185,000,000 -15,896,000,000 -15,567,000,000 -15,241,000,000 -15,002,000,000 -14,754,000,000 -14,508,000,000 -14,289,000,000 -14,090,000,000 -13,798,000,000 -13,514,000,000 -13,242,000,000 -13,038,000,000 -12,752,000,000 -12,458,000,000 
        investments of insurance subsidiaries
      		387,000,000 573,000,000 531,000,000 550,000,000 569,000,000 553,000,000 483,000,000 471,000,000 477,000,000 382,000,000 384,000,000 390,000,000 381,000,000 372,000,000 379,000,000 408,000,000 438,000,000 418,000,000 410,000,000 393,000,000 388,000,000 390,000,000 364,000,000 325,000,000 315,000,000 357,000,000 342,000,000 338,000,000 362,000,000 367,000,000 414,000,000 417,000,000 418,000,000 368,000,000 352,000,000 349,000,000 336,000,000 354,000,000 341,000,000 425,000,000 432,000,000 409,000,000 404,000,000 435,000,000 494,000,000 441,000,000 426,000,000 453,000,000 448,000,000 402,000 405,000 423,000,000 515,000,000 473,000,000 495,000,000 536,000,000 548,000,000            
        investments in and advances to affiliates
      		615,000,000 654,000,000 654,000,000 657,000,000 662,000,000 705,000,000 702,000,000 736,000,000 756,000,000 739,000,000 731,000,000 786,000,000 823,000,000 444,000,000 435,000,000 441,000,000 448,000,000 412,000,000 382,000,000 427,000,000 422,000,000 335,000,000 275,000,000 238,000,000 249,000,000 243,000,000 247,000,000 246,000,000 232,000,000 238,000,000 234,000,000 231,000,000 199,000,000 201,000,000 197,000,000 194,000,000 206,000,000 216,000,000 201,000,000 174,000,000 178,000,000 186,000,000 182,000,000 181,000,000 165,000,000 167,000,000 150,000,000 142,000,000 121,000,000 125,000 120,000 107,000,000 104,000,000 103,000,000 102,000,000 108,000,000 101,000,000 837,000,000 843,000,000 852,000,000 869,000,000 857,000,000 870,000,000 851,000,000 853,000,000 855,000,000 854,000,000 860,000,000 
        goodwill and other intangible assets
      		10,504,000,000 10,275,000,000 10,273,000,000 10,237,000,000 10,093,000,000 9,982,000,000 9,963,000,000 9,967,000,000 9,945,000,000 9,778,000,000 9,641,000,000 9,590,000,000 9,653,000,000 9,651,000,000 9,593,000,000 9,525,000,000 9,540,000,000 9,153,000,000 8,680,000,000 8,575,000,000 8,578,000,000 8,570,000,000 8,578,000,000 8,587,000,000 8,269,000,000 8,160,000,000 8,140,000,000 8,159,000,000 7,953,000,000 7,759,000,000 7,459,000,000 7,471,000,000 7,394,000,000 7,357,000,000 6,771,000,000 6,754,000,000 6,704,000,000 6,691,000,000 6,694,000,000 6,713,000,000 6,731,000,000 6,540,000,000 6,484,000,000 6,415,000,000 6,416,000,000 5,899,000,000 5,909,000,000 5,910,000,000 5,903,000,000 5,832,000 5,534,000 5,541,000,000 5,539,000,000 5,460,000,000 5,431,000,000 5,398,000,000 5,251,000,000            
        right-of-use operating lease assets
      		2,094,000,000 2,115,000,000 2,156,000,000 2,132,000,000 2,131,000,000 2,201,000,000 2,179,000,000 2,211,000,000 2,207,000,000 2,079,000,000 2,110,000,000 2,032,000,000 2,065,000,000 2,097,000,000 2,139,000,000 2,138,000,000 2,113,000,000 2,099,000,000 2,118,000,000 2,083,000,000 2,024,000,000 1,972,000,000 1,863,000,000 1,828,000,000 1,834,000,000 1,770,000,000 1,787,000,000 1,812,000,000                                         
        liabilities and stockholders’ (deficit) equity
      		                                                                    
        current liabilities:
      		                                                                    
        accounts payable
      		4,806,000,000 4,552,000,000 4,250,000,000 4,488,000,000 4,276,000,000 4,235,000,000 4,029,000,000 4,735,000,000 4,233,000,000 4,139,000,000 3,823,000,000 3,769,000,000 4,239,000,000 4,161,000,000 3,742,000,000 4,010,000,000 4,111,000,000 3,759,000,000 3,531,000,000 3,524,000,000 3,535,000,000 3,270,000,000 2,882,000,000 2,750,000,000 2,905,000,000 2,610,000,000 2,609,000,000 2,693,000,000 2,577,000,000 2,414,000,000 2,457,000,000 2,538,000,000 2,606,000,000 2,314,000,000 2,245,000,000 2,233,000,000 2,318,000,000 1,950,000,000 1,934,000,000 1,944,000,000 2,170,000,000 1,877,000,000 1,884,000,000 1,973,000,000 2,035,000,000 1,787,000,000 1,717,000,000 1,735,000,000 1,803,000,000 1,582,000 1,657,000 1,691,000,000 1,768,000,000 1,585,000,000 1,517,000,000 1,412,000,000 1,597,000,000 1,334,000,000 1,297,000,000 1,348,000,000 1,537,000,000 1,254,000,000 1,179,000,000 1,199,000,000 1,460,000,000 1,199,000,000 1,206,000,000 1,200,000,000 
        accrued salaries
      		2,022,000,000 2,294,000,000 2,072,000,000 1,857,000,000 2,304,000,000 2,164,000,000 1,993,000,000 1,759,000,000 2,127,000,000 1,912,000,000 1,776,000,000 1,565,000,000 1,712,000,000 1,625,000,000 1,895,000,000 1,865,000,000 1,912,000,000 2,134,000,000 1,896,000,000 1,767,000,000 1,720,000,000 1,971,000,000 1,631,000,000 1,560,000,000 1,775,000,000 1,669,000,000 1,497,000,000 1,424,000,000 1,580,000,000 1,456,000,000 1,315,000,000 1,238,000,000 1,369,000,000 1,312,000,000 1,209,000,000 1,150,000,000 1,265,000,000 1,241,000,000 1,405,000,000 1,309,000,000 1,233,000,000 1,358,000,000 1,282,000,000 1,180,000,000 1,370,000,000 1,238,000,000 1,140,000,000 1,052,000,000 1,193,000,000 1,085,000 1,036,000 969,000,000 1,120,000,000 1,027,000,000 970,000,000 909,000,000 965,000,000 876,000,000 1,009,000,000 975,000,000 895,000,000 1,007,000,000 927,000,000 893,000,000 849,000,000 954,000,000 876,000,000 823,000,000 
        other accrued expenses
      		3,898,000,000 4,940,000,000 4,513,000,000 3,767,000,000 3,899,000,000 3,819,000,000 3,705,000,000 3,619,000,000 3,871,000,000 3,803,000,000 3,551,000,000 3,316,000,000 3,581,000,000 3,780,000,000 3,116,000,000 3,157,000,000 3,322,000,000 3,481,000,000 2,935,000,000 3,117,000,000 3,240,000,000 2,843,000,000 3,181,000,000 2,547,000,000 2,932,000,000 2,697,000,000 2,782,000,000 2,618,000,000 2,624,000,000 2,170,000,000 2,161,000,000 2,005,000,000 1,983,000,000 1,783,000,000 2,104,000,000 1,868,000,000 2,035,000,000 1,748,000,000 1,833,000,000 1,919,000,000 1,880,000,000 1,701,000,000 1,770,000,000 1,982,000,000 1,737,000,000 1,563,000,000 1,992,000,000 2,063,000,000 1,913,000,000 1,764,000 1,871,000 1,893,000,000 1,849,000,000 1,498,000,000 1,651,000,000 1,453,000,000 1,585,000,000 1,336,000,000 1,283,000,000 1,398,000,000 1,245,000,000 1,373,000,000 1,262,000,000 1,498,000,000 1,158,000,000 1,316,000,000 1,119,000,000 1,458,000,000 
        short-term borrowings and long-term debt due within one year
      		8,532,000,000 6,110,000,000 5,104,000,000                                                                  
        current liabilities: - sum
      		19,258,000,000     14,900,000,000 14,301,000,000  12,655,000,000 12,407,000,000 11,545,000,000  9,902,000,000 9,784,000,000 8,999,000,000 10,518,000,000 9,582,000,000                                            4,269,000,000 4,330,000,000   4,313,000,000 4,104,000,000  3,897,000,000 
        long-term debt, less debt issuance costs and discounts of 433 and 436
      		39,491,000,000                                                                    
        professional liability risks
      		1,509,000,000 1,462,000,000 1,506,000,000 1,497,000,000 1,544,000,000 1,584,000,000 1,573,000,000 1,571,000,000 1,557,000,000 1,590,000,000 1,554,000,000 1,565,000,000 1,528,000,000 1,510,000,000 1,533,000,000 1,508,000,000 1,514,000,000 1,522,000,000 1,585,000,000 1,553,000,000 1,486,000,000 1,434,000,000 1,485,000,000 1,432,000,000 1,370,000,000 1,349,000,000 1,354,000,000 1,313,000,000 1,275,000,000 1,239,000,000 1,283,000,000 1,244,000,000 1,198,000,000 1,179,000,000 1,144,000,000 1,134,000,000 1,148,000,000 1,164,000,000 1,126,000,000 1,116,000,000 1,115,000,000 1,117,000,000 1,132,000,000 1,095,000,000 1,078,000,000 1,045,000,000 1,019,000,000 978,000,000 949,000,000 959,000 960,000 970,000,000 973,000,000 962,000,000 1,039,000,000 1,030,000,000 993,000,000 993,000,000 987,000,000 1,003,000,000 995,000,000 1,027,000,000 1,029,000,000 1,058,000,000 1,057,000,000 1,097,000,000 1,108,000,000 1,098,000,000 
        right-of-use operating lease obligations
      		1,822,000,000 1,838,000,000 1,881,000,000 1,860,000,000 1,863,000,000 1,924,000,000 1,894,000,000 1,912,000,000 1,903,000,000 1,776,000,000 1,806,000,000 1,716,000,000 1,752,000,000 1,762,000,000 1,796,000,000 1,790,000,000 1,755,000,000 1,742,000,000 1,767,000,000 1,730,000,000 1,673,000,000 1,635,000,000 1,531,000,000 1,497,000,000 1,499,000,000 1,440,000,000 1,460,000,000 1,494,000,000                                         
        income taxes and other liabilities
      		2,348,000,000 2,309,000,000 2,069,000,000 2,191,000,000 2,041,000,000 1,982,000,000 1,966,000,000 1,905,000,000 1,867,000,000 1,666,000,000 1,691,000,000 1,692,000,000 1,615,000,000 1,714,000,000 1,741,000,000 1,768,000,000 2,060,000,000 2,800,000,000 2,088,000,000 2,032,000,000 1,940,000,000 1,477,000,000 1,490,000,000 1,477,000,000 1,420,000,000 1,349,000,000 1,324,000,000 1,277,000,000 1,248,000,000 1,388,000,000 1,459,000,000 1,417,000,000 1,374,000,000 1,256,000,000 1,282,000,000 1,253,000,000 1,249,000,000 1,746,000,000 1,953,000,000 1,933,000,000 1,904,000,000 1,903,000,000 1,860,000,000 1,837,000,000 1,832,000,000 1,740,000,000 1,554,000,000 1,524,000,000 1,525,000,000 1,670,000 1,695,000 1,763,000,000 1,776,000,000 1,860,000,000 1,857,000,000 1,757,000,000 1,720,000,000 1,683,000,000 1,515,000,000 1,507,000,000 1,608,000,000 1,611,000,000 1,589,000,000 1,742,000,000 1,768,000,000 1,782,000,000 1,713,000,000 1,853,000,000 
        stockholders’ (deficit) equity:
      		                                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 222,530,900 shares — 2026 and 224,605,100 shares — 2025
      		2,000,000                                                                    
        accumulated other comprehensive loss
      		-327,000,000 -317,000,000 -309,000,000 -357,000,000 -387,000,000 -378,000,000 -433,000,000 -433,000,000 -425,000,000 -491,000,000 -456,000,000 -470,000,000 -490,000,000 -592,000,000 -515,000,000 -447,000,000 -404,000,000 -492,000,000 -475,000,000 -491,000,000 -502,000,000 -515,000,000 -562,000,000 -571,000,000 -460,000,000 -461,000,000 -431,000,000 -374,000,000 -381,000,000 -266,000,000 -261,000,000 -197,000,000 -278,000,000 -268,000,000 -293,000,000 -320,000,000 -338,000,000 -341,000,000 -344,000,000 -294,000,000 -265,000,000 -309,000,000 -290,000,000 -344,000,000 -323,000,000 -206,000,000 -199,000,000 -232,000,000 -257,000,000 -374,000 -426,000 -475,000,000 -457,000,000 -440,000,000 -449,000,000 -411,000,000 -440,000,000 -424,000,000 -339,000,000 -344,000,000 -428,000,000 -494,000,000 -505,000,000 -479,000,000 -450,000,000 -505,000,000 -498,000,000 -608,000,000 
        retained deficit
      		-5,978,000,000 -5,020,000,000 -4,087,000,000 -3,164,000,000 -2,115,000,000 -1,807,000,000 -1,170,000,000 -1,185,000,000 -1,352,000,000 -1,989,000,000 -1,850,000,000 -2,028,000,000 -2,280,000,000 -2,781,000,000 -3,168,000,000 -1,589,000,000      -647,000,000 -1,315,000,000 -2,394,000,000 -2,351,000,000 -3,107,000,000 -3,474,000,000 -3,983,000,000 -4,572,000,000 -5,342,000,000 -5,731,000,000 -6,051,000,000 -6,532,000,000 -6,516,000,000 -6,503,000,000 -6,701,000,000 -6,968,000,000 -7,426,000,000 -7,767,000,000 -7,266,000,000 -7,338,000,000 -6,989,000,000 -7,120,000,000 -7,280,000,000 -7,575,000,000 -8,054,000,000 -8,572,000,000 -9,055,000,000 -9,403,000,000 -9,827,000 -10,193,000 -10,616,000,000 -10,960,000,000 -9,103,000,000 -9,463,000,000 -9,854,000,000 -9,423,000,000 -11,358,000,000 -11,419,000,000 -11,648,000,000 -11,888,000,000 -10,090,000,000 -10,333,000,000 -10,126,000,000 -8,763,000,000 -8,979,000,000 -9,175,000,000 -9,457,000,000 
        stockholders’ deficit attributable to hca healthcare, inc.
      		-6,303,000,000 -5,335,000,000 -4,394,000,000 -3,519,000,000 -2,499,000,000 -2,182,000,000 -1,600,000,000 -1,615,000,000 -1,774,000,000 -2,477,000,000 -2,303,000,000 -2,495,000,000 -2,767,000,000 -3,370,000,000 -3,680,000,000 -2,033,000,000      -974,000,000 -1,786,000,000 -2,962,000,000 -2,808,000,000 -3,565,000,000 -3,902,000,000 -4,354,000,000 -4,950,000,000 -5,605,000,000 -5,989,000,000 -6,244,000,000 -6,806,000,000 -6,780,000,000 -6,792,000,000 -7,017,000,000                                 
        noncontrolling interests
      		3,325,000,000 3,176,000,000 3,156,000,000 3,081,000,000 3,054,000,000 2,968,000,000 2,939,000,000 2,885,000,000 2,834,000,000 2,834,000,000 2,764,000,000 2,727,000,000 2,694,000,000 2,592,000,000 2,538,000,000 2,447,000,000 2,422,000,000 2,520,000,000 2,383,000,000 2,235,000,000 2,320,000,000 2,273,000,000 2,354,000,000 2,259,000,000 2,243,000,000 2,118,000,000 2,132,000,000 2,099,000,000 2,032,000,000 1,875,000,000 1,864,000,000 1,810,000,000 1,811,000,000 1,714,000,000 1,713,000,000 1,660,000,000 1,669,000,000 1,600,000,000 1,609,000,000 1,557,000,000 1,553,000,000 1,482,000,000 1,451,000,000 1,398,000,000 1,396,000,000 1,366,000,000 1,402,000,000 1,361,000,000 1,342,000,000 1,332,000 1,338,000 1,311,000,000 1,319,000,000 1,296,000,000 1,300,000,000 1,289,000,000 1,244,000,000 1,132,000,000 1,147,000,000 1,142,000,000 1,132,000,000 1,017,000,000 1,017,000,000 1,015,000,000 1,008,000,000 990,000,000 1,005,000,000 1,019,000,000 
        long-term debt, less debt issuance costs and discounts of 416 and 369
      		 38,401,000,000                                                                   
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 229,845,100 shares — 2025 and 249,981,400 shares — 2024
      		 2,000,000                                                                   
        long-term debt, less debt issuance costs and discounts of 429 and 369
      		  39,379,000,000                                                                  
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 236,143,900 shares — 2025 and 249,981,400 shares — 2024
      		  2,000,000                                                                  
        long-term debt due within one year
      		   3,519,000,000 4,698,000,000 4,682,000,000 4,574,000,000 3,028,000,000 2,424,000,000 2,553,000,000 2,395,000,000 2,378,000,000 370,000,000 218,000,000 246,000,000 1,486,000,000 237,000,000 250,000,000 253,000,000 234,000,000 209,000,000 172,000,000 163,000,000 162,000,000 145,000,000 148,000,000 2,073,000,000 3,796,000,000 788,000,000 191,000,000 1,692,000,000 1,697,000,000 200,000,000 202,000,000 213,000,000 212,000,000 216,000,000 216,000,000 224,000,000 226,000,000 233,000,000 1,377,000,000 1,374,000,000 2,037,000,000 338,000,000 1,044,000,000 1,046,000,000 1,041,000,000 786,000,000 988,000 1,456,000 1,438,000,000 1,435,000,000 1,751,000,000 1,309,000,000 1,841,000,000 1,407,000,000 725,000,000 689,000,000 546,000,000 592,000,000 696,000,000 1,029,000,000 981,000,000 846,000,000 635,000,000 194,000,000 416,000,000 
        long-term debt, less debt issuance costs and discounts of 432 and 369
      		   41,057,000,000                                                                 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 242,955,400 shares — 2025 and 249,981,400 shares — 2024
      		   2,000,000                                                                 
        property and equipment, at cost:
      		                                                                    
        land
      		    3,295,000,000    3,120,000,000    2,799,000,000    2,496,000,000    2,269,000,000    2,178,000,000    1,944,000,000    1,746,000,000    1,611,000,000    1,524,000,000    1,524,000,000    1,487,000,000    1,429,000,000    1,416,000,000    1,215,000,000    1,202,000,000    
        buildings
      		    22,691,000,000    21,560,000,000    20,221,000,000    19,211,000,000    18,471,000,000    17,669,000,000    15,659,000,000    14,249,000,000    13,546,000,000    12,533,000,000    11,941,000,000    11,211,000,000    10,720,000,000    10,231,000,000    9,438,000,000    9,108,000,000    
        equipment
      		    34,670,000,000    31,998,000,000    29,981,000,000    28,256,000,000    27,082,000,000    25,756,000,000    23,577,000,000    22,168,000,000    20,580,000,000    19,335,000,000    18,496,000,000    17,519,000,000    16,430,000,000    15,431,000,000    14,310,000,000    13,575,000,000    
        construction in progress
      		    1,858,000,000    1,870,000,000    1,756,000,000    1,387,000,000    1,495,000,000    1,632,000,000    1,785,000,000    1,921,000,000    1,318,000,000    1,222,000,000    1,019,000,000    856,000,000    948,000,000    997,000,000    678,000,000    784,000,000    
        liabilities and stockholders’ equity
      		                                                                    
        long-term debt, less debt issuance costs and discounts of 369 and 333
      		    38,333,000,000                                                                
        stockholders’ equity
      		                                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 249,981,400 shares — 2024 and 265,537,300 shares — 2023
      		    3,000,000                                                                
        long-term debt, less debt issuance costs and discounts of 378 and 333
      		     38,283,000,000                                                               
        stockholders’ equity:
      		                                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 254,517,700 shares — 2024 and 265,537,300 shares — 2023
      		     3,000,000                                                               
        long-term debt, less debt issuance costs and discounts of 371 and 333
      		      36,306,000,000                                                              
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 259,237,600 shares — 2024 and 265,537,300 shares — 2023
      		      3,000,000                                                              
        long-term debt, less debt issuance costs and discounts of 381 and 333
      		       37,163,000,000                                                             
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 263,215,800 shares — 2024 and 265,537,300 shares — 2023
      		       3,000,000                                                             
        property and equipment, at cost: - sum
      		        58,548,000,000    54,757,000,000    51,350,000,000                                            25,641,000,000    24,669,000,000    
        long-term debt, less debt issuance costs and discounts of 333 and 301
      		        37,169,000,000                                                            
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 265,537,300 shares — 2023 and 277,378,300 shares — 2022
      		        3,000,000                                                            
        long-term debt, less debt issuance costs and discounts of 341 and 301
      		         36,793,000,000                                                           
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 268,967,300 shares — 2023 and 277,378,300 shares — 2022
      		         3,000,000                                                           
        long-term debt, less debt issuance costs and discounts of 349 and 301
      		          36,537,000,000                                                          
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares — 2023 and 277,378,300 shares — 2022
      		          3,000,000                                                          
        long-term debt, less debt issuance costs and discounts of 295 and 301
      		           36,478,000,000                                                         
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 275,939,900 shares — 2023 and 277,378,300 shares — 2022
      		           3,000,000                                                         
        long-term debt, less debt issuance costs and discounts of 301 and 248
      		            37,714,000,000                                                        
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 277,378,300 shares — 2022 and 305,476,800 shares — 2021
      		            3,000,000                                                        
        long-term debt, less debt issuance costs and discounts of 309 and 248
      		             37,492,000,000                                                       
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 283,903,500 shares — 2022 and 305,476,800 shares — 2021
      		             3,000,000                                                       
        long-term debt, less debt issuance costs and discounts of 316 and 248
      		              38,657,000,000                                                      
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 287,004,400 shares — 2022 and 305,476,800 shares — 2021
      		              3,000,000                                                      
        long-term debt, less debt issuance costs and discounts of 323 and 248
      		               36,210,000,000                                                     
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021
      		               3,000,000                                                     
        long-term debt, less debt issuance costs and discounts of 248 and 236
      		                34,342,000,000                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 305,476,800 shares — 2021 and 339,425,600 shares — 2020
      		                3,000,000                                                    
        capital in excess of par value
      		                    294,000,000 185,000,000 88,000,000                       872,000,000 777,000,000 1,455,000,000 1,386,000,000 1,821,000 1,792,000 1,764,000,000 1,753,000,000 1,680,000,000 1,665,000,000 1,648,000,000 1,601,000,000 1,584,000,000 3,072,000,000 3,057,000,000 389,000,000 324,000,000 312,000,000 291,000,000 226,000,000 204,000,000 186,000,000 176,000,000 
        retained earnings
      		                -532,000,000   735,000,000 777,000,000                                                
        stockholders’ equity (deficit) attributable to hca healthcare, inc.
      		                -933,000,000    572,000,000                                                
        long-term debt, less debt issuance costs and discounts of 253 and 236
      		                 32,049,000,000                                                   
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 313,502,400 shares — 2021 and 339,425,600 shares — 2020
      		                 3,000,000                                                   
        retained (deficit) earnings
      		                 -206,000,000 -121,000,000                                                  
        stockholders’ (deficit) equity attributable to hca healthcare, inc.
      		                 -695,000,000 -593,000,000                                                  
        long-term debt, less debt issuance costs and discounts of 255 and 236
      		                  32,319,000,000                                                  
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 322,824,800 shares — 2021 and 339,425,600 shares — 2020
      		                  3,000,000                                                  
        long-term debt, less debt issuance costs and discounts of 229 and 236
      		                   30,838,000,000                                                 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 333,714,500 shares — 2021 and 339,425,600 shares — 2020
      		                   3,000,000                                                 
        stockholders’ equity attributable to hca healthcare, inc.
      		                   247,000,000                                                 
        long-term debt, less debt issuance costs and discounts of 236 and 239
      		                    30,795,000,000                                                
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 339,425,600 shares — 2020 and 338,445,600 shares — 2019
      		                    3,000,000                                                
        government stimulus refund liability
      		                     6,123,000,000                                               
        long-term debt, less debt issuance costs and discounts of 245 and 239
      		                     30,792,000,000                                               
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,370,500 shares in 2020 and 338,445,600 shares in 2019
      		                     3,000,000                                               
        liabilities and stockholders’ deficit
      		                                                                    
        contract liabilities-deferred revenues
      		                      4,999,000,000                                              
        long-term debt, less debt issuance costs and discounts of 252 and 239
      		                      30,779,000,000                                              
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,960,400 shares in 2020 and 338,445,600 shares in 2019
      		                      3,000,000                                              
        long-term debt, less debt issuance costs and discounts of 258 and 239
      		                       34,699,000,000                                             
        stockholders’ deficit:
      		                                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,607,500 shares in 2020 and 338,445,600 shares in 2019
      		                       3,000,000                                             
        long-term debt, less debt issuance costs and discounts of 239 and 157
      		                        33,577,000,000                                            
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,445,600 shares — 2019 and 342,895,200 shares — 2018
      		                        3,000,000                                            
        long-term debt, less debt issuance costs and discounts of 244 and 157
      		                         34,097,000,000                                           
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 340,053,100 shares in 2019 and 342,895,200 shares in 2018
      		                         3,000,000                                           
        long-term debt, less debt issuance costs and discounts of 252 and 157
      		                          34,120,000,000                                          
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 341,516,800 shares in 2019 and 342,895,200 shares in 2018
      		                          3,000,000                                          
        long-term debt, less net debt issuance costs of 170 and 157
      		                           31,019,000,000                                         
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 343,030,500 shares in 2019 and 342,895,200 shares in 2018
      		                           3,000,000                                         
        long-term debt, less net debt issuance costs of 157 and 164
      		                            32,033,000,000                                        
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 342,895,200 shares—2018 and 350,091,600 shares—2017
      		                            3,000,000                                        
        long-term debt, less net debt issuance costs of 163 and 164
      		                             32,916,000,000                                       
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 345,085,800 shares in 2018 and 350,091,600 shares in 2017
      		                             3,000,000                                       
        balances, december 31, 2016
      		                             370,536,000       370,536,000                                
        comprehensive income
      		                                                                    
        repurchase of common stock
      		                             -5,121,000       -28,583,000    -10,656,000     -750,000,000                       
        share-based benefit plans
      		                             3,280,000       9,457,000    7,060,000                            
        distributions
      		                                                                    
        balances, march 31, 2017
      		                             368,695,000                                       
        balances, june 30, 2017
      		                             362,895,000                                       
        balances, september 30, 2017
      		                             356,980,000                                       
        balances, december 31, 2017
      		                             350,092,000                                       
        cash dividends declared
      		                                                                    
        balances, march 31, 2018
      		                             350,987,000                                       
        balances, june 30, 2018
      		                             346,760,000                                       
        balances, september 30, 2018
      		                             345,086,000                                       
        long-term debt, less net debt issuance costs of 151 and 164
      		                              31,500,000,000                                      
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 346,760,200 shares in 2018 and 350,091,600 shares in 2017
      		                              3,000,000                                      
        long-term debt, less net debt issuance costs of 158 and 164
      		                               31,594,000,000                                     
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,987,500 shares in 2018 and 350,091,600 shares in 2017
      		                               4,000,000                                     
        accounts receivables
      		                                6,501,000,000 5,980,000,000 5,782,000,000 5,664,000,000 5,826,000,000 5,503,000,000 5,669,000,000 5,880,000,000 5,889,000,000 5,827,000,000 5,804,000,000 5,928,000,000 5,694,000,000 5,524,000,000 5,472,000,000 5,489,000,000 5,208,000,000 4,924,000 4,915,000 4,877,000,000 4,672,000,000 4,598,000,000 4,485,000,000 4,878,000,000 4,533,000,000 3,925,000,000 3,946,000,000 4,060,000,000 3,832,000,000 3,636,000,000 3,769,000,000 3,878,000,000 3,692,000,000 3,499,000,000 3,680,000,000 3,870,000,000 
        long-term debt, less net debt issuance costs of 164 and 170
      		                                32,858,000,000                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,091,600 shares—2017 and 370,535,900 shares—2016
      		                                4,000,000                                    
        long-term debt, less net debt issuance costs of 171 and 170
      		                                 32,751,000,000                                   
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 356,979,800 shares in 2017 and 370,535,900 shares in 2016
      		                                 4,000,000                                   
        long-term debt, less net debt issuance costs of 179 and 170
      		                                  31,448,000,000                                  
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 362,895,000 shares in 2017 and 370,535,900 shares in 2016
      		                                  4,000,000                                  
        cash flows from operating activities:
      		                                                                    
        net income
      		                                  1,572,000,000    1,602,000,000   1,958,000,000    1,697,000,000  454,000,000      1,579,000,000 1,124,000,000 639,000,000             
        adjustments to reconcile net income to net cash from operating activities:
      		                                                                    
        increase in cash from operating assets and liabilities:
      		                                                                    
        benefit from doubtful accounts
      		                                  1,833,000,000    1,552,000,000   2,839,000,000    2,337,000,000  851,000,000      2,666,000,000 1,835,000,000 794,000,000             
        inventories and other assets
      		                                  -178,000,000    -176,000,000   -205,000,000                           
        accounts payable and accrued expenses
      		                                  -298,000,000    -102,000,000   -152,000,000                           
        depreciation and amortization
      		                                  1,042,000,000    968,000,000   1,424,000,000    1,361,000,000  447,000,000      1,254,000,000 837,000,000 417,000,000             
        income taxes
      		                                  267,000,000    67,000,000   -148,000,000    -61,000,000  144,000,000      250,000,000 326,000,000 300,000,000             
        gains on sales of facilities
      		                                  -3,000,000    -5,000,000   -2,000,000                           
        legal claim costs
      		                                      22,000,000   77,000,000    78,000,000  78,000,000                     
        amortization of debt issuance costs
      		                                  16,000,000    18,000,000   27,000,000                           
        share-based compensation
      		                                  140,000,000    129,000,000   171,000,000    118,000,000  37,000,000      39,000,000 23,000,000 9,000,000             
        net cash from operating activities
      		                                  2,684,000,000    2,748,000,000   3,176,000,000    2,821,000,000  443,000,000      2,912,000,000 2,257,000,000 797,000,000             
        cash flows from investing activities:
      		                                                                    
        purchase of property and equipment
      		                                  -1,304,000,000    -1,172,000,000   -1,571,000,000    -1,482,000,000  -400,000,000      -1,268,000,000 -784,000,000 -335,000,000             
        acquisition of hospitals and health care entities
      		                                  -295,000,000    -430,000,000   -184,000,000    -97,000,000  -19,000,000      -167,000,000 -139,000,000 -112,000,000             
        disposal of hospitals and health care entities
      		                                  14,000,000    14,000,000   27,000,000                           
        change in investments
      		                                  -11,000,000    18,000,000   94,000,000    22,000,000  -13,000,000      73,000,000 35,000,000 6,000,000             
        net cash from investing activities
      		                                  -1,591,000,000    -1,555,000,000   -1,631,000,000    -1,512,000,000  -409,000,000      -1,340,000,000 -886,000,000 -437,000,000             
        cash flows from financing activities:
      		                                                                    
        issuances of long-term debt
      		                                  1,502,000,000    3,000,000,000   4,048,000,000                           
        net change in revolving bank credit facilities
      		                                  -1,160,000,000       -270,000,000                           
        repayment of long-term debt
      		                                  -95,000,000    -2,065,000,000   -3,702,000,000    -3,525,000,000  -542,000,000      -689,000,000 -608,000,000 -93,000,000             
        distributions to noncontrolling interests
      		                                  -248,000,000    -205,000,000   -367,000,000    -325,000,000  -87,000,000      -303,000,000 -191,000,000 -93,000,000             
        payment of debt issuance costs
      		                                  -25,000,000    -24,000,000   -34,000,000    -49,000,000  -48,000,000      -20,000,000 -19,000,000 -16,000,000             
        repurchases of common stock
      		                                  -966,000,000    -1,858,000,000   -1,386,000,000                           
        net cash from financing activities
      		                                  -1,034,000,000    -1,243,000,000   -1,523,000,000    -1,208,000,000  402,000,000      -1,473,000,000 -1,226,000,000 -262,000,000             
        change in cash and cash equivalents
      		                                  59,000,000    -50,000,000   22,000,000    101,000,000  436,000,000      99,000,000 145,000,000 98,000,000             
        cash and cash equivalents at beginning of period
      		                                  646,000,000    741,000,000   566,000,000    414,000,000  414,000,000      373,000,000 373,000,000 373,000,000             
        cash and cash equivalents at end of period
      		                                  705,000,000    691,000,000   588,000,000    515,000,000  850,000,000      472,000,000 518,000,000 471,000,000             
        interest payments
      		                                  834,000,000    767,000,000   1,349,000,000    1,441,000,000  523,000,000      1,404,000,000 854,000,000 517,000,000             
        income tax payments
      		                                  387,000,000    558,000,000   864,000,000    758,000,000                       
        long-term debt, less net debt issuance costs of 165 and 170
      		                                   31,302,000,000                                 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 368,694,700 shares in 2017 and 370,535,900 shares in 2016
      		                                   4,000,000                                 
        long-term debt, less net debt issuance costs of 170 and 167
      		                                    31,160,000,000                                
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 370,535,900 shares — 2016 and 398,738,700 shares — 2015
      		                                    4,000,000                                
        stockholders’ deficit attributable to hca holdings, inc.
      		                                    -7,302,000,000 -7,763,000,000 -8,107,000,000 -7,556,000,000 -7,599,000,000 -7,294,000,000 -7,406,000,000 -7,620,000,000 -7,894,000,000 -7,384,000,000 -7,990,000,000 -7,828,000,000 -8,270,000,000 -8,376,000 -8,823,000 -9,323,000,000 -9,660,000,000 -7,859,000,000 -8,243,000,000 -8,613,000,000 -8,258,000,000 -10,194,000,000 -8,681,000,000 -8,930,000,000 -11,926,000,000        
        balances, december 31, 2013
      		                                    439,604,000    439,604,000                            
        balances, december 31, 2014
      		                                    420,478,000    420,478,000                            
        acquisition of entities with noncontrolling interests
      		                                                                    
        balances, december 31, 2015
      		                                    398,739,000    398,739,000                            
        long-term debt, less net debt issuance costs of 178 and 167
      		                                     31,225,000,000                               
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 376,140,800 shares in 2016 and 398,738,700 shares in 2015
      		                                     4,000,000                               
        long-term debt, less net debt issuance costs of 173 and 167
      		                                      31,228,000,000                              
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 380,061,600 shares in 2016 and 398,738,700 shares in 2015
      		                                      4,000,000                              
        losses on retirement of debt
      		                                         125,000,000    226,000,000                       
        long-term debt, less net debt issuance costs of 179 and 167
      		                                       30,328,000,000                             
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 393,650,000 shares in 2016 and 398,738,700 shares in 2015
      		                                       4,000,000                             
        deferred income taxes
      		                                         412,000,000 376,000,000 304,000,000 366,000,000 320,000,000 500,000,000 492,000,000 489,000,000 400,000 401,000 385,000,000 385,000,000 322,000,000 323,000,000 226,000,000 594,000,000 643,000,000 894,000,000 916,000,000 931,000,000 1,045,000,000 1,126,000,000 1,181,000,000 1,192,000,000 1,099,000,000 1,032,000,000 988,000,000 
        long-term debt, less net debt issuance costs of 167 and 219
      		                                        30,255,000,000  28,363,000,000                          
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 398,738,700 shares — 2015 and 420,477,900 shares — 2014
      		                                        4,000,000                            
        balances, december 31, 2012
      		                                        443,200,000                            
        long-term debt, less net debt issuance costs of 160 and 219
      		                                         28,375,000,000                           
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 412,638,300 shares in 2015 and 420,477,900 shares in 2014
      		                                         4,000,000                           
        decrease in cash from operating assets and liabilities:
      		                                                                    
        income tax benefits
      		                                         231,000,000    119,000,000  50,000,000      82,000,000 71,000,000 49,000,000             
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 416,348,900 shares in 2015 and 420,477,900 shares in 2014
      		                                          4,000,000                          
        long-term debt, less debt issuance costs of 220 and 219
      		                                           27,406,000,000                         
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 419,179,100 shares in 2015 and 420,477,900 shares in 2014
      		                                           4,000,000                         
        deferred loan costs
      		                                            219,000,000 221,000,000 230,000,000 271,000,000 237,000,000 250,000 264,000 274,000,000 290,000,000 266,000,000 281,000,000 292,000,000 290,000,000 297,000,000 332,000,000 354,000,000 374,000,000 371,000,000 391,000,000 411,000,000 418,000,000 436,000,000 444,000,000 452,000,000 
        long-term debt
      		                                            29,307,000,000 27,426,000,000 27,942,000,000 27,883,000,000 27,590,000,000 27,389,000 26,744,000 27,170,000,000 27,495,000,000 25,182,000,000 25,732,000,000 26,061,000,000 25,645,000,000 25,871,000,000 24,631,000,000 24,820,000,000 27,633,000,000 25,383,000,000 25,769,000,000 25,874,000,000 24,824,000,000 25,279,000,000 26,351,000,000 26,151,000,000 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 420,477,900 shares — 2014 and 439,604,000 shares — 2013
      		                                            4,000,000                        
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 433,378,700 shares in 2014 and 439,604,000 shares in 2013
      		                                             4,000,000                       
        changes in operating assets and liabilities
      		                                             -2,945,000,000  -1,561,000,000      -2,923,000,000 -1,927,000,000 -1,384,000,000             
        losses (gains) on sales of facilities
      		                                             -20,000,000  -21,000,000      -4,000,000               
        amortization of deferred loan costs
      		                                             33,000,000  14,000,000      44,000,000 29,000,000 14,000,000             
        disposition of hospitals and health care entities
      		                                             38,000,000  23,000,000      17,000,000 6,000,000 1,000,000             
        issuance of long-term debt
      		                                             3,502,000,000  3,502,000,000      1,350,000,000 1,350,000,000 1,350,000,000             
        net change in revolving credit facilities
      		                                             -160,000,000  -2,440,000,000      -875,000,000 -820,000,000 -470,000,000             
        distributions to stockholders
      		                                             -7,000,000  -7,000,000      -983,000,000 -982,000,000 -982,000,000             
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 431,372,800 shares in 2014 and 439,604,000 shares in 2013
      		                                              4,000,000                      
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 444,201,100 shares in 2014 and 439,604,000 shares in 2013
      		                                               4,000,000                     
        loss on retirement of debt
      		                                                                    
        income tax payments (refunds)
      		                                               32,000,000      428,000,000 141,000,000              
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 439,604,000 shares — 2013 and 443,200,200 shares — 2012
      		                                                4,000,000                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,573,400 shares in 2013 and 443,200,200 shares in 2012
      		                                                 4,000                   
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,066,900 shares in 2013 and 443,200,200 shares in 2012
      		                                                  4,000                  
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 445,856,200 shares in 2013 and 443,200,200 shares in 2012
      		                                                   4,000,000                 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 443,200,200 shares — 2012 and 437,477,900 shares — 2011
      		                                                    4,000,000                
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 441,383,000 shares in 2012 and 437,477,900 shares in 2011
      		                                                     4,000,000               
        pay-in-kind interest
      		                                                                    
        issuance of common stock
      		                                                                    
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 440,483,600 shares in 2012 and 437,477,900 shares in 2011
      		                                                      4,000,000              
        losses on sales of facilities
      		                                                      3,000,000 1,000,000             
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 438,354,100 shares in 2012 and 437,477,900 shares in 2011
      		                                                       4,000,000             
        income tax refunds
      		                                                       -25,000,000             
        equity securities with contingent redemption rights
      		                                                            141,000,000 144,000,000 144,000,000 144,000,000 147,000,000 147,000,000 155,000,000 154,000,000 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 437,477,900 shares — 2011 and 427,458,800 shares — 2010
      		                                                        4,000,000            
        investments of insurance subsidiary
      		                                                         545,000,000 515,000,000 590,000,000 642,000,000 665,000,000 646,000,000 1,146,000,000 1,166,000,000 1,371,000,000 1,322,000,000 1,302,000,000 
        goodwill
      		                                                         2,701,000,000 2,719,000,000 2,705,000,000 2,693,000,000 2,610,000,000 2,583,000,000 2,561,000,000 2,577,000,000 2,596,000,000 2,594,000,000 2,579,000,000 
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 436,483,900 shares in 2011 and 427,458,800 shares in 2010
      		                                                         4,000,000           
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 517,094,100 shares in 2011 and 427,458,800 shares in 2010
      		                                                          5,000,000          
        common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 515,614,300 shares in 2011 and 427,458,800 shares in 2010
      		                                                           5,000,000         
        common stock 0.01 par; authorized 125,000,000 shares — 2010 and 2009; outstanding 94,885,500 shares — 2010 and 94,637,400 shares — 2009
      		                                                            1,000,000        
        common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,644,100 shares in 2010 and 94,637,400 shares in 2009
      		                                                             1,000,000       
        stockholders’ deficit attributable to hca inc.
      		                                                             -10,259,000,000 -10,525,000,000 -10,313,000,000 -8,986,000,000 -9,279,000,000 -9,486,000,000 -9,888,000,000 
        common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,638,800 shares in 2010 and 94,637,400 shares in 2009
      		                                                              1,000,000      
        common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,626,100 shares in 2010 and 94,637,400 shares in 2009
      		                                                               1,000,000     
        common stock 0.01 par; authorized 125,000,000 shares — 2009 and 2008; outstanding 94,637,400 shares — 2009 and 94,367,500 shares — 2008
      		                                                                1,000,000    
        common stock .01 par; authorized 125,000,000 shares; outstanding 94,614,500 shares in 2009 and 94,367,500 shares in 2008
      		                                                                 1,000,000   
        common stock .01 par; authorized 125,000,000 shares; outstanding 94,409,800 shares in 2009 and 94,367,500 shares in 2008
      		                                                                  1,000,000  
        common stock .01 par; authorized 125,000,000 shares; outstanding 94,378,600 shares in 2009 and 94,367,500 shares in 2008
      		                                                                   1,000,000 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-06-30 2022-03-31 2010-09-30 2009-09-30 2009-03-31 
                      
          cash flows from operating activities:
        		              
          net income
        		5,619,000,000 3,716,000,000 1,825,000,000 4,971,000,000 3,489,000,000 1,802,000,000 4,230,000,000 2,955,000,000 1,543,000,000 2,844,000,000 1,465,000,000 1,179,000,000 1,071,000,000 432,000,000 
          adjustments to reconcile net income to net cash from operating activities:
        		              
          increase in cash from operating assets and liabilities:
        		              
          accounts receivable
        		345,000,000 320,000,000 -327,000,000 55,000,000 -285,000,000 -90,000,000 -168,000,000 306,000,000 238,000,000 -547,000,000 -427,000,000    
          inventories and other assets
        		-125,000,000 -427,000,000 -360,000,000 184,000,000 -68,000,000 77,000,000 -274,000,000 -301,000,000 -214,000,000 -462,000,000 -121,000,000    
          accounts payable and accrued expenses
        		29,000,000 -676,000,000 -1,000,000,000 77,000,000 -459,000,000 -517,000,000 211,000,000 -505,000,000 -1,066,000,000 -818,000,000 -771,000,000    
          depreciation and amortization
        		2,612,000,000 1,723,000,000 860,000,000 2,456,000,000 1,614,000,000 795,000,000 2,288,000,000 1,519,000,000 756,000,000 1,470,000,000 732,000,000 1,062,000,000 1,067,000,000 353,000,000 
          income taxes
        		1,314,000,000 880,000,000 492,000,000 -67,000,000 -4,000,000 444,000,000 61,000,000 3,000,000 372,000,000 121,000,000 346,000,000 -10,000,000 -485,000,000 41,000,000 
          losses on sales of facilities
        		4,000,000 2,000,000  -209,000,000 -213,000,000 -201,000,000 12,000,000 14,000,000 15,000,000 22,000,000  2,000,000 8,000,000 5,000,000 
          amortization of debt issuance costs and discounts
        		32,000,000 25,000,000 11,000,000 26,000,000 17,000,000 9,000,000 26,000,000 17,000,000 9,000,000 15,000,000 7,000,000    
          share-based compensation
        		301,000,000 197,000,000 98,000,000 275,000,000 199,000,000 87,000,000 205,000,000 133,000,000 77,000,000 171,000,000 86,000,000 24,000,000 21,000,000 7,000,000 
          other
        		146,000,000 101,000,000 53,000,000 187,000,000 150,000,000 63,000,000 166,000,000 137,000,000 73,000,000 81,000,000 38,000,000 29,000,000 52,000,000 12,000,000 
          net cash from operating activities
        		10,277,000,000 5,861,000,000 1,651,000,000 7,955,000,000 4,440,000,000 2,469,000,000 6,757,000,000 4,278,000,000 1,803,000,000 2,975,000,000 1,345,000,000 2,611,000,000 2,315,000,000 567,000,000 
          capital expenditures
        		-3,455,000,000 -2,167,000,000 -991,000,000 -3,590,000,000 -2,399,000,000 -1,118,000,000 -3,585,000,000 -2,438,000,000 -1,197,000,000 -1,941,000,000 -861,000,000 -860,000,000 -915,000,000 -337,000,000 
          free cash flows
        		6,822,000,000 3,694,000,000 660,000,000 4,365,000,000 2,041,000,000 1,351,000,000 3,172,000,000 1,840,000,000 606,000,000 1,034,000,000 484,000,000 1,751,000,000 1,400,000,000 230,000,000 
          cash flows from investing activities:
        		              
          purchase of property and equipment
        		-3,455,000,000 -2,167,000,000 -991,000,000 -3,590,000,000 -2,399,000,000 -1,118,000,000 -3,585,000,000 -2,438,000,000 -1,197,000,000 -1,941,000,000 -861,000,000 -860,000,000 -915,000,000 -337,000,000 
          acquisition of hospitals and health care entities
        		-361,000,000 -326,000,000 -227,000,000 -224,000,000 -131,000,000 -96,000,000 -281,000,000 -124,000,000 -115,000,000 -116,000,000 -2,000,000 -35,000,000 -42,000,000 -38,000,000 
          sales of hospitals and health care entities
        		177,000,000 167,000,000 161,000,000 312,000,000 311,000,000 310,000,000 183,000,000 172,000,000 165,000,000 20,000,000 14,000,000    
          change in investments
        		-26,000,000 41,000,000 28,000,000 -85,000,000 -14,000,000 2,000,000 -30,000,000 -16,000,000 -13,000,000 -2,000,000 10,000,000 473,000,000 113,000,000 76,000,000 
          net cash from investing activities
        		-3,671,000,000 -2,283,000,000 -1,032,000,000 -3,587,000,000 -2,235,000,000 -903,000,000 -3,720,000,000 -2,408,000,000 -1,151,000,000 -2,050,000,000 -845,000,000 -398,000,000 -807,000,000 -288,000,000 
          cash flows from financing activities:
        		              
          issuance of long-term debt
        		5,233,000,000 5,233,000,000 5,233,000,000 7,495,000,000 4,483,000,000 4,483,000,000 3,220,000,000 3,218,000,000  5,966,000,000 5,966,000,000 1,387,000,000 2,979,000,000 300,000,000 
          net change in short-term borrowings and revolving credit facilities
        		1,906,000,000 1,768,000,000             
          repayment of long-term debt
        		-5,834,000,000 -5,660,000,000 -3,895,000,000 -2,346,000,000 -2,269,000,000 -2,066,000,000 -691,000,000 -608,000,000 -550,000,000 -2,690,000,000 -66,000,000 -2,020,000,000 -3,050,000,000 -339,000,000 
          distributions to noncontrolling interests
        		-631,000,000 -394,000,000 -220,000,000 -530,000,000 -338,000,000 -152,000,000 -497,000,000 -342,000,000 -187,000,000 -333,000,000 -171,000,000 -282,000,000 -254,000,000  
          payment of debt issuance costs
        		-57,000,000 -57,000,000 -57,000,000 -67,000,000 -40,000,000 -40,000,000 -31,000,000 -30,000,000 -3,000,000 -53,000,000 -49,000,000 -25,000,000 -68,000,000  
          payment of dividends
        		-517,000,000 -351,000,000 -180,000,000 -525,000,000 -356,000,000 -185,000,000 -501,000,000 -339,000,000 -175,000,000 -337,000,000 -177,000,000    
          repurchase of common stock
        		-7,509,000,000 -5,011,000,000 -2,506,000,000 -4,342,000,000 -2,547,000,000 -1,180,000,000 -2,901,000,000 -1,761,000,000 -846,000,000 -4,783,000,000 -2,101,000,000    
          net cash from financing activities
        		-7,551,000,000 -4,584,000,000 -1,495,000,000 -2,419,000,000 -2,309,000,000 -1,216,000,000 -3,055,000,000 -1,923,000,000 -725,000,000 -1,501,000,000 425,000,000 -2,148,000,000 -1,530,000,000 -388,000,000 
          effect of exchange rate changes on cash and cash equivalents
        		9,000,000 12,000,000 3,000,000 4,000,000  -1,000,000 1,000,000 7,000,000 7,000,000 -17,000,000 -5,000,000    
          change in cash and cash equivalents
        		-936,000,000 -994,000,000 -873,000,000 1,953,000,000 -104,000,000 349,000,000 -17,000,000 -46,000,000 -66,000,000 -593,000,000 920,000,000 65,000,000 -22,000,000 -109,000,000 
          cash and cash equivalents at beginning of period
        		1,933,000,000 1,933,000,000 1,933,000,000 935,000,000 935,000,000 935,000,000 908,000,000 908,000,000 908,000,000 1,451,000,000 1,451,000,000 312,000,000 465,000,000 465,000,000 
          cash and cash equivalents at end of period
        		997,000,000 939,000,000 1,060,000,000 2,888,000,000 831,000,000 1,284,000,000 891,000,000 862,000,000 842,000,000 858,000,000 2,371,000,000 377,000,000 443,000,000 356,000,000 
          interest payments
        		1,696,000,000 1,074,000,000 539,000,000 1,405,000,000 943,000,000 538,000,000 1,460,000,000 925,000,000 574,000,000 777,000,000 408,000,000 1,399,000,000 1,154,000,000 344,000,000 
          income tax payments
        		227,000,000 146,000,000 10,000,000 1,486,000,000 999,000,000 1,000,000 1,070,000,000 773,000,000 7,000,000 609,000,000  498,000,000 965,000,000 146,000,000 
          gains on sales of facilities
        		  -1,000,000        -10,000,000    
          net change in revolving credit facilities
        		  220,000,000 -1,880,000,000 -1,030,000,000 -1,880,000,000 -1,420,000,000 -1,840,000,000 1,240,000,000 930,000,000 -2,780,000,000 1,035,000,000 -1,125,000,000  
          losses on retirement of debt
        		         78,000,000     
          issuances of long-term debt
        		              
          losses (gains) on sales of facilities
        		              
          amortization of debt issuance costs
        		              
          decrease in cash from operating assets and liabilities:
        		              
          income tax payments (refunds)
        		          3,000,000    
          contract liabilities-deferred revenues
        		              
          income tax refunds
        		              
          government stimulus refund liability
        		              
          net change in revolving bank credit facilities
        		              
          repurchases of common stock
        		              
          income tax (refunds) payments
        		              
          disposal of hospitals and health care entities
        		              
          payment of cash dividends
        		              
          legal claim benefits
        		              
          effect on exchange rate changes in cash and cash equivalents
        		              
          benefit from doubtful accounts
        		              
          legal claim costs
        		              
          income tax benefits
        		              
          distributions to stockholders
        		              
          amortization of deferred loan costs
        		           60,000,000 60,000,000 21,000,000 
          changes in operating assets and liabilities
        		           -1,927,000,000 -2,136,000,000 -1,111,000,000 
          disposition of hospitals and health care entities
        		           26,000,000 39,000,000 5,000,000 
          loss on retirement of debt
        		              
          gain on acquisition of controlling interest in equity investment
        		              
          pay-in-kind interest
        		            58,000,000 39,000,000 
          issuance of common stock
        		              
          impairments of long-lived assets
        		           119,000,000   
          contributions from noncontrolling interests
        		              
          provision for doubtful accounts
        		           2,073,000,000 2,583,000,000 807,000,000 
          income tax payments, net of refunds
        		              
          payment of cash distributions to stockholders
        		           -2,251,000,000   
          payment of cash distribution to stockholders
        		              
          impairment of long-lived assets
        		            16,000,000 9,000,000 
          issuances of common stock
        		              
          net change in revolving bank credit facility
        		             -335,000,000 
          change in noncontrolling interests
        		             -48,000,000